Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Patients with Multiple Sclerosis: A Single-Center Retrospective Study and Literature Review.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
05 2021
Historique:
received: 08 12 2020
revised: 15 02 2021
accepted: 16 02 2021
pubmed: 1 3 2021
medline: 6 8 2021
entrez: 28 2 2021
Statut: ppublish

Résumé

Trigeminal neuralgia (TN) in patients with multiple sclerosis (MS) is a challenging condition to manage that is treated with Gamma Knife radiosurgery (GKRS). The aim of this report is to assess the safety, efficacy, and durability of GKRS for the treatment of TN in patients with MS. Our findings are compared with those of the existing literature and discussed. We retrospectively reviewed all patients at our institution who underwent GKRS for the treatment of TN secondary to MS and had 1 or more years of follow-up. Preoperative and postoperative pain intensities and facial numbness were evaluated with the Barrow Neurological Institute scores. Durability of successful pain relief was statistically evaluated with Kaplan-Meier analysis. The prognostic role of perioperative factors was investigated and analyzed using Cox proportional hazards regression. There were 29 patients with MS-TN who underwent GKRS at our institution. Two patients underwent bilateral treatment. Four patients underwent repeat GKRS for pain recurrence. The median period of follow-up assessment was 33 months. Rates of reasonable pain reduction at 1, 3, and 5 years were 70%, 57%, and 57% respectively. All patients who underwent repeat GKRS had durable pain reduction. No prognostic factor for successful pain reduction was found. Our study shows that GKRS for the treatment of TN secondary to MS is a safe and effective procedure in controlling pain in the short term but often fails to provide long-term pain control. GKRS can be safely repeated to prolong the time of pain reduction.

Identifiants

pubmed: 33640527
pii: S1878-8750(21)00267-9
doi: 10.1016/j.wneu.2021.02.074
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e92-e100

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Andrea Franzini (A)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy. Electronic address: andrea.franzini1@hotmail.it.

Maria Pia Tropeano (MP)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Simone Olei (S)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Mario De Robertis (M)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Zefferino Rossini (Z)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Luca Attuati (L)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Davide Milani (D)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Federico Pessina (F)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Elena Clerici (E)

Department of Radiation Oncology, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Pierina Navarria (P)

Department of Radiation Oncology, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Piero Picozzi (P)

Department of Neurosurgery, Humanitas Clinical and Research Center - IRCCS, Rozzano (Mi), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH